Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.202 USD | +0.20% | -0.63% | -16.50% |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 62.64 | 31.85 | 15.82 | 10.14 | 6.259 | 5.867 | - | - |
Enterprise Value (EV) 1 | 62.64 | 31.85 | 5.389 | 10.14 | 6.259 | 5.867 | 5.867 | 5.867 |
P/E ratio | -7.37 x | -4.09 x | -1.03 x | -0.82 x | -0.63 x | -0.66 x | -1.05 x | - |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - | - | - |
EV / EBITDA | - | - | -11,21,908 x | - | - | - | - | - |
EV / FCF | -1,26,61,159 x | - | -13,08,549 x | - | - | - | - | - |
FCF Yield | -0% | - | -0% | - | - | - | - | - |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 405 | 537 | 959 | 1,300 | 4,346 | 4,889 | - | - |
Reference price 2 | 154.8 | 59.25 | 16.50 | 7.800 | 1.440 | 1.200 | 1.200 | 1.200 |
Announcement Date | 02/03/20 | 16/03/21 | 30/03/22 | 31/03/23 | 28/03/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - |
EBITDA | - | - | -14.1 | - | - | - | - | - |
EBIT 1 | -7.715 | -7.302 | -14.1 | -11.07 | -7.692 | -11.8 | -16 | - |
Operating Margin | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -7.705 | -7.213 | -14.31 | -11.37 | -7.845 | -11.8 | -16 | - |
Net income 1 | -7.705 | -7.213 | -14.31 | -11.37 | -7.845 | -11.8 | -16 | - |
Net margin | - | - | - | - | - | - | - | - |
EPS 2 | -21.00 | -14.50 | -16.00 | -9.500 | -2.300 | -1.815 | -1.140 | - |
Free Cash Flow | -4.947 | - | -12.09 | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 02/03/20 | 16/03/21 | 30/03/22 | 31/03/23 | 28/03/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | -3.253 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -3.253 | -3.38 | -2.661 | -2.3 | -2.684 | -3.421 | -2.193 | -1.709 | -2.093 | -1.698 | -2.4 | -2.8 | -3.1 | -3.5 | - |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -3.296 | -3.48 | -2.572 | -2.678 | -2.644 | -3.479 | -2.184 | -1.873 | -2.087 | -1.702 | -2.4 | -2.8 | -3.1 | -3.5 | - |
Net income 1 | -3.296 | -3.48 | -2.572 | -2.678 | -2.644 | -3.479 | -2.184 | -1.873 | -2.087 | -1.702 | -2.4 | -2.8 | -3.1 | -3.5 | - |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -3.500 | -3.500 | -2.750 | -2.250 | -2.050 | -2.720 | -0.8800 | -0.5700 | -0.6000 | -0.3100 | -0.4300 | -0.4000 | -0.4400 | -0.3900 | -0.3600 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 10/11/21 | 30/03/22 | 12/05/22 | 12/08/22 | 10/11/22 | 31/03/23 | 15/05/23 | 11/08/23 | 13/11/23 | 28/03/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | 10.4 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow | -4.95 | - | -12.1 | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | - | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - | - |
Announcement Date | 02/03/20 | 16/03/21 | 30/03/22 | 31/03/23 | 28/03/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.50% | 5.87M | |
+30.65% | 695B | |
+26.51% | 568B | |
-4.63% | 361B | |
+19.60% | 330B | |
+3.79% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+7.87% | 168B |
- Stock Market
- Equities
- HOTH Stock
- Financials Hoth Therapeutics, Inc.